Paper40632811
HIV-1 Vpr orchestrates ciTRAN upregulation through TGF-β induction.
Choudhary A and 3 others. PLoS Pathog, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. HIV-1 Vpr orchestrates ciTRAN upregulation through TGF-β induction. Papers, record 40632811. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40632811
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV-1 | Major topic |
| Transforming Growth Factor beta | Major topic |
| vpr Gene Products, Human Immunodeficiency Virus | Major topic |
| HIV Infections | Major topic |
| Intracellular Signaling Peptides and Proteins | Major topic |
| Humans | |
| Up-Regulation | |
| RNA, Circular | |
| Signal Transduction |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed |
Source PubMed
References89
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15018667 | Increased plasma transforming growth factor-beta1 is associated with disease progression in HIV-1-infected patients. | Viral Immunol | 2004 | https://conductscience.org/library/papers/15018667 | PubMed |
| 2 | 19818703 | A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. | Cell Stem Cell | 2009 | https://conductscience.org/library/papers/19818703 | PubMed |
| 3 | 19022294 | A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants. | J Virol Methods | 2009 | https://conductscience.org/library/papers/19022294 | PubMed |
| 4 | 31019079 | HIV-1 Vpr counteracts HLTF-mediated restriction of HIV-1 infection in T cells. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31019079 | PubMed |
| 5 | 38110484 | Transcriptomic study reveals changes of lncRNAs in PBMCs from HIV-1 patients before and after ART. | Sci Rep | 2023 | https://conductscience.org/library/papers/38110484 | PubMed |
| 6 | 24412650 | Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing. | Cell | 2014 | https://conductscience.org/library/papers/24412650 | PubMed |
| 7 | 38025783 | Vpr attenuates antiviral immune responses and is critical for full pathogenicity of SIVmac239 in rhesus macaques. | iScience | 2023 | https://conductscience.org/library/papers/38025783 | PubMed |
| 8 | 18541215 | HIV-1 accessory proteins--ensuring viral survival in a hostile environment. | Cell Host Microbe | 2008 | https://conductscience.org/library/papers/18541215 | PubMed |
| 9 | 22319583 | Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. | PLoS One | 2012 | https://conductscience.org/library/papers/22319583 | PubMed |
| 10 | 26416734 | HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation. | Nature | 2015 | https://conductscience.org/library/papers/26416734 | PubMed |
| 11 | 37882652 | Regulatory circular RNAs in viral diseases: applications in diagnosis and therapy. | RNA Biol | 2023 | https://conductscience.org/library/papers/37882652 | PubMed |
| 12 | 21566118 | Molecular insight into how HIV-1 Vpr protein impairs cell growth through two genetically distinct pathways. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21566118 | PubMed |
| 13 | 9427608 | HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. | Nat Med | 1998 | https://conductscience.org/library/papers/9427608 | PubMed |
| 14 | 7474080 | Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. | J Virol | 1995 | https://conductscience.org/library/papers/7474080 | PubMed |
| 15 | 2136707 | Identification of HIV-1 vpr product and function. | J Acquir Immune Defic Syndr (1988) | 1990 | https://conductscience.org/library/papers/2136707 | PubMed |
| 16 | 33300875 | HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport. | Elife | 2020 | https://conductscience.org/library/papers/33300875 | PubMed |
| 17 | 17688698 | Endogenous TGF-beta activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25- T cells. | Retrovirology | 2007 | https://conductscience.org/library/papers/17688698 | PubMed |
| 18 | 24624335 | OpenComet: an automated tool for comet assay image analysis. | Redox Biol | 2014 | https://conductscience.org/library/papers/24624335 | PubMed |
| 19 | 25185158 | New tricks for an old fox: impact of TGFβ on the DNA damage response and genomic stability. | Sci Signal | 2014 | https://conductscience.org/library/papers/25185158 | PubMed |
| 20 | 35402072 | Improved loss-of-function CRISPR-Cas9 genome editing in human cells concomitant with inhibition of TGF-β signaling. | Mol Ther Nucleic Acids | 2022 | https://conductscience.org/library/papers/35402072 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42820270 | Circular RNA functions in HIV-1 infection. | RNA Biol | 2026 | https://conductscience.org/library/papers/42820270 | PubMed |
| 42657874 | CircRNA0857 acts as an miRNA sponge to promote Newcastle disease virus replication via modulating autophagy. | J Virol | 2026 | https://conductscience.org/library/papers/42657874 | PubMed |
| 41963297 | Immune modulatory vaccines targeting tumor microenvironment antigens: recent advances in oncology and beyond. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41963297 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| QKI | 9444 | PubTator's text mining | https://conductscience.org/library/genes/9444 | NCBI Gene |
| SMARCA5 | 8467 | PubTator's text mining | https://conductscience.org/library/genes/8467 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
| TGFBR1 | 7046 | PubTator's text mining | https://conductscience.org/library/genes/7046 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40632811
GET https://conductscience.org/api/papers/v1/40632811/references?page=2